Dr. John Cush RheumNow
2 years 8 months ago
Sarcoid arthritis (SA) seen in 19% of sarcoid pts. Metanalsysis of 49 articles (8574 pts) found Ankles most frequent (80%) followed by knees & wrists. Monoarthritis was uncommon (1%). Acute , 0-2, I2 55%). Acute SA (oligo & poly) was linked to E nodosum. https://t.co/XPbS4vVX9o https://t.co/CqonQ1a3wW
Abatacept has been studied in seropositive clinically suspect arthralgia patients (at risk for rheumatoid arthritis) and shows the potential to delay or prevent the disease.
Dr. John Cush RheumNow
2 years 8 months ago
In 551 juvenile myositis pts, 36% had myositis assoc Abs (MAA); 13% had >1 MAA. MAA+ pts had more overlap dz (18 vs 6%, p<.001) & assoc w/ Raynauds (OR 2.44), ILD (OR 3.43), chronic Dz (OR 1.72), mortality (OR 3.76). # MAAs was assoc w/ mortality (OR 1.83) https://t.co/gvHIEuiG66
Dr. John Cush RheumNow
2 years 8 months ago
Study of 43 SSc patients w/ gangrene shows Smoking Hx ; positive-ACA, ANCA, APL Abs & high ESR were independent risk factors for digital gangrenes in SSc. Vasculitis and macrovascular disease may contribute to the progression of digital gangrene https://t.co/YmwurwymLb https://t.co/RiOIkbIEXM
Dr. John Cush RheumNow
2 years 8 months ago
Transcriptome analysis (of PBMCs) looked for differential gene expression btwn 125 SJIA & 92 healthy controls identified 4 key genes (ALDH1A1, CEACAM1, YBX3 and SLC6A8) distinguishing SJIA; & may aid in diagnosis. https://t.co/M6pfajw3U3 https://t.co/VVwrYUJcBH
Dr. John Cush RheumNow
2 years 8 months ago
#RWCS24
New diabetes meds include https://t.co/xOnH3jm6Jy
Dr. John Cush RheumNow
2 years 8 months ago
Dr. Orrin Troum at #RWCS24 lecturing on GLP1 agonists and other diabetes therapies in rheum pts. #RWCS24 https://t.co/jzJk8xGNxz
Dr. John Cush RheumNow
2 years 8 months ago
Sweets syndrome and manifestations #rwcs24 https://t.co/8Hev4Cmu8z
Dr. John Cush RheumNow
2 years 8 months ago
Dr. Anisha Dua at #RWCS24 lecturing on vasculitis mimics https://t.co/Bo31icqn7S
The antidiabetic and weight-loss drug semaglutide (Ozempic, Wegovy, Rybelsus) either does or does not help patients undergoing total hip arthroplasty (THA) avoid complications and other poor outcomes, according to two retrospective studies presented here.
Dr. John Cush RheumNow
2 years 8 months ago
Catastrophic APL has high mortality.. Use of triple Rx w pulse steroids, IV heparin and plasma exchange still only has 50% survival. #RWCS24 https://t.co/ycttHcpmjL
Dr. John Cush RheumNow
2 years 8 months ago
Congratulations to Dr. Megan Clowse - named the new chief of the Division of Rheumatology and Immunology at Duke University School of Medicine, Durham, N.C. !! @clowse https://t.co/d6iCEHlF3F
Dr. John Cush RheumNow
2 years 8 months ago
Obesity increase risk of psoriasis
Obesity increase risk of PsA in psoriasis pts RWCS24 https://t.co/Wt9h0QLbKH
Dr. John Cush RheumNow
2 years 8 months ago
Obesity is assoc w higher CRP.
Losing weight lowers CRP RWCS24 https://t.co/Gc6TKtmOgI
Dr. John Cush RheumNow
2 years 8 months ago
Higher adipose in RA linked to atherosclerosis but protects against erosions RWCS24 https://t.co/qsFMhj4LyZ
